<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02094846</url>
  </required_header>
  <id_info>
    <org_study_id>Evaluation with cell phones</org_study_id>
    <nct_id>NCT02094846</nct_id>
  </id_info>
  <brief_title>Evaluation of an Intervention Based on Cell Phones</brief_title>
  <official_title>Evaluation of the Effect of an Intervention Based on Cell Phones on Glycemic Control in Adults With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Salud Publica, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Salud Publica, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to assess the effect of an individualized intervention based on cell
      phones to improve glycemic control in patients with type 2 diabetes attending Epidemiology
      Research Unit in Cuernavaca, Morelos. Mexico
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study before randomization, the participants received workshops on diet, physical
      activity, glycemic index of foods.

      Bandura´s theoretical model was used in the voice messages sent to the intervention group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>Glycated hemoglobin is obtained from a blood sample at the beginning of the study and 3 months later.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Low Density Lipoprotein</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>Low Density Lipoprotein is obtained from a blood sample at the beginning of the study and 3 months later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoprotein</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>High Density Lipoprotein is obtained from a blood sample at the beginning of the study and 3 months later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>Cholesterol is obtained from a blood sample at the beginning of the study and 3 months later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>Self-efficacy questionnaire is divided into a diet´s self-efficacy questionnaire and physical activity´s self-efficacy questionnaire.
People can obtained &quot;low self-efficacy&quot; status or &quot;high self-efficacy&quot; status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>Basal and 3 months</time_frame>
    <description>A triaxial accelerometer was used, colocated on the hip and the participants were supposed to use it 7 days for a minimal of 10 hours per day</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Voice messages</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group receive voice messages to reinforce given information about diet, physical activity, glycemic index</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Messages</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group received voice messages with fun facts.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voice messages</intervention_name>
    <description>Voice messages reinforced with self-efficacy</description>
    <arm_group_label>Voice messages</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 2 diabetes mellitus &gt; 10 years

          -  Glycated hemoglobin &gt;7%

        Exclusion Criteria:

          -  Take insulin regularly

          -  Pregnant woman

          -  Woman who expected to be pregnant the next 6 months

          -  24 hrs creatinine &lt; 30 ml/minute
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario E Flores Aldanda, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Salud Pública</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unidad de Investigación en Epidemiología y Servicios de Salud del Instituto Mexicano del Seguro Social</name>
      <address>
        <city>Cuernavaca</city>
        <state>Morelos</state>
        <zip>62450</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/17881285</url>
    <description>Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes</description>
  </link>
  <reference>
    <citation>Oh JA, Kim HS, Yoon KH, Choi ES. A telephone-delivered intervention to improve glycemic control in type 2 diabetic patients. Yonsei Med J. 2003 Feb;44(1):1-8.</citation>
    <PMID>12619168</PMID>
  </reference>
  <reference>
    <citation>Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, Huang J, Wang L, Gu D. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011 Apr;28(4):455-63. doi: 10.1111/j.1464-5491.2010.03180.x.</citation>
    <PMID>21392066</PMID>
  </reference>
  <reference>
    <citation>Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56-69. doi: 10.1093/epirev/mxq004. Epub 2010 Mar 30. Review.</citation>
    <PMID>20354039</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2014</study_first_posted>
  <last_update_submitted>March 20, 2014</last_update_submitted>
  <last_update_submitted_qc>March 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Salud Publica, Mexico</investigator_affiliation>
    <investigator_full_name>Mario Efraín Flores Aldana</investigator_full_name>
    <investigator_title>Jefe del Departamento de Epidemiología Nutricional. Centro de Investigación en Nutrición y Salud</investigator_title>
  </responsible_party>
  <keyword>Cellular phones</keyword>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Glycated hemoglobin</keyword>
  <keyword>glycemic control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

